河北医学2024,Vol.30Issue(4) :549-555.DOI:10.3969/j.issn.1006-6233.2024.04.04

美沙拉嗪对小鼠溃疡性结肠炎模型中Let-7i-5p/TLR4/MyD88依赖性通路的调控机制

Regulatory Mechanism of Mesalazine on Let-7i-5p/TLR4/MyD88 Signaling Pathway in a Mouse Model of Ulcerative Colitis

毛珍珍 刘靖 张晨华 闫娜娜 赵玲玲 卢军仪 许伟光 王婧
河北医学2024,Vol.30Issue(4) :549-555.DOI:10.3969/j.issn.1006-6233.2024.04.04

美沙拉嗪对小鼠溃疡性结肠炎模型中Let-7i-5p/TLR4/MyD88依赖性通路的调控机制

Regulatory Mechanism of Mesalazine on Let-7i-5p/TLR4/MyD88 Signaling Pathway in a Mouse Model of Ulcerative Colitis

毛珍珍 1刘靖 1张晨华 1闫娜娜 2赵玲玲 2卢军仪 2许伟光 1王婧1
扫码查看

作者信息

  • 1. 河北省沧州中西医结合医院/沧州市第二人民医院, 河北 沧州 061000
  • 2. 河北省盐山县人民医院, 河北 盐山 061300
  • 折叠

摘要

目的:本研究旨在探讨美沙拉嗪(MSLZ)对小鼠2,4,6-三硝基苯磺酸(TNBS)模型中Let-7i-5p和TLR4/MyD88 依赖通路的调控机制.方法:采用 TNBS/乙醇结肠法建立溃疡性结肠炎(UC)模型.将44 只雄性小鼠随机分为对照组、模型组、MSLZ组和Let-7i-5p抑制剂组,每组11 只.小鼠灌胃或腹腔注射相应的药物或生理盐水,连续14d.采用实时荧光定量聚合酶链反应(qRT-PCR)检测小鼠结肠组织中和血清中Let-7i-5p的表达水平.在显微镜下,用苏木精和伊红(HE)染色观察结肠组织的病理病变.分别采用qRT-PCR,Western blot 和免疫组化方法检测小鼠结肠组织中 TLR4/MyD88 依赖通路相关基因的mRNA和蛋白水平.通过ELISA检测小鼠血清中TNF-α和IL-1β的表达水平.结果:根据疾病活跃指数(DAI)、结肠损伤和病理病变的评分,成功构建了小鼠 UC 模型.模型组小鼠结肠组织中和血清中Let-7i-5p的表达水平显著高于对照组(P<0.0001).与模型组相比,MSLZ 和 Let-7i-5p抑制剂处理均能显著抑制Let-7i-5p的表达(P<0.0001).与对照组相比,模型组小鼠结肠组织中TLR4/MyD88 依赖通路相关基因(包括TLR4、MyD88、TRAF-6 和NF-κB)的mRNA和蛋白水平显著上调.MSLZ和Let-7i-5p抑制剂处理均能显著抑制这些基因的表达,且MSLZ的抑制作用略强于Let-7i-5p抑制剂.与对照组相比,模型组小鼠结肠组织中IL-1β和TNF-α的mRNA水平和血清中的蛋白水平显著上调,MSLZ和Let-7i-5p抑制剂处理均能抑制IL-1β和TNF-α的表达水平.结论:在TNBS/乙醇诱导的UC小鼠模型中,MSLZ可以抑制结肠组织中和血清中Let-7i-5p 的表达.此外,MSLZ还通过抑制UC小鼠的TLR4/MyD88 依赖性通路来抑制炎症因子的释放.

Abstract

Objective:To investigate the regulatory mechanism of mesalazine(MSLZ)on Let-7i-5p and TLR4/MyD88 signaling pathway in a mouse model of 2,4,6-trinitrobenzene sulfonic acid(TNBS)-in-duced ulcerative colitis(UC).Methods:A UC model was established using the TNBS/ethanol method.Forty-four male mice were randomly divided into four groups:control group,model group,MSLZ group,and Let-7i-5p inhibitor group,with 11 mice in each group.Mice were gavaged or intraperitoneally injected with corre-sponding drugs or saline for 14 consecutive days.The expression levels of Let-7i-5p in colon tissues and ser-um of mice were detected by real-time quantitative polymerase chain reaction(qRT-PCR).The pathological changes of colon tissues were observed by hematoxylin and eosin(HE)staining under a microscope.The mR-NA and protein levels of TLR4/MyD88 signaling pathway-related genes in colon tissues of mice were detected by qRT-PCR,Western blot,and immunohistochemistry,respectively.The expression levels of TNF-α and IL-1β in mouse serum were detected by ELISA.Results:According to the disease activity index(DAI),co-lon damage score,and pathological lesion score,the mouse UC model was successfully established.The ex-pression levels of Let-7i-5p in colon tissues and serum of mice in the model group were significantly higher than those in the control group(P<0.0001).Compared with the model group,both MSLZ and Let-7i-5p in-hibitor treatment could significantly inhibit the expression of Let-7i-5p(P<0.0001).Compared with the control group,the mRNA and protein levels of TLR4/MyD88 signaling pathway-related genes(including TLR4,MyD88,TRAF-6,and NF-κB)in colon tissues of mice in the model group were significantly upregu-lated.MSLZ and Let-7i-5p inhibitor treatment could significantly inhibit the expression of these genes,and the inhibitory effect of MSLZ was slightly stronger than that of Let-7i-5p inhibitor.Compared with the control group,the mRNA levels of IL-1β and TNF-α in colon tissues and the protein levels in serum of mice in the model group were significantly upregulated.MSLZ and Let-7i-5p inhibitor treatment could inhibit the expres-sion levels of IL-1β and TNF-α.Conclusion:In the TNBS/ethanol-induced UC mouse model,MSLZ can inhibit the expression of Let-7i-5p in colon tissues and serum.In addition,MSLZ can also inhibit the release of inflammatory factors by inhibiting the TLR4/MyD88-dependent pathway in UC mice.

关键词

溃疡性结肠炎/美沙拉嗪/Let-7i-5p/TLR4/MyD88依赖性通路

Key words

Ulcerative colitis/Mesalazine/Let-7i-5p/TLR4/MyD88-dependent pathway

引用本文复制引用

基金项目

河北省中医药局科研项目(2024178)

出版年

2024
河北医学
河北省医学会

河北医学

CSTPCD
影响因子:1.915
ISSN:1006-6233
参考文献量9
段落导航相关论文